New report puts Victoria on top
25 July, 2002 by Tanya HollisVictoria has cemented its reputation as Australia's biotechnology and bioscience industry leader, which was initiated with the introduction of the smallpox vaccine 80 years ago, a report has found.
Plasvacc heads for the fast-track
25 July, 2002 by Pete YoungOne of the rare biotech companies with origins in rural Australia, Plasvacc Pty Ltd, is dropping its low-key strategy and moving into fast-track expansion mode.
Flinders teams with pharma Elan in Parkinson's research
25 July, 2002 by Melissa TrudingerA research team at Flinders University in South Australia is collaborating with biopharmaceutical company Elan Pharmaceuticals on a project investigating Parkinson's disease.
Vic biotech projects net $60m in second-round grants
25 July, 2002 by Tanya HollisVictoria's government unveiled its second round of Science, Technology and Innovation Grants today, with almost $60 million being poured into mostly biotechnology projects.
Grain Biotech walks with the giants in international tech awards
25 July, 2002 by Melissa TrudingerAn Australian agbiotech company has been named as a finalist in this year's World Technology Awards for its excellence in wheat transformation.
AusBiotech to wave the flag for pre-clinical industry
24 July, 2002 by Tanya HollisIndustry organisation AusBiotech is to set up a working group to deliver the recommendations of a pre-clinical development meeting held in Melbourne this week.
CSIRO scientists isolate semi-dwarfing rice gene
24 July, 2002 by Melissa TrudingerResearchers at CSIRO Plant Industry have used the publicly available rice genome sequence to isolate the semi-dwarfing gene in varieties responsible for the 'green revolution' and develop 'perfect' markers for it.
BresaGen parts company with British Biotech
24 July, 2002 by Tanya HollisAdelaide-based company BresaGen and British Biotech have ended a collaboration to develop GM-CSF antagonist E21R, after fresh tests failed to confirm previous assessments of its commercial prospects.
Processed coral may be used in bone grafts
23 July, 2002 by Melissa TrudingerA group based at the University of Technology, Sydney, has developed a unique method of processing coral, which may allow it to be used in orthopaedic implants.
Pre-clinical stage needs work, conference hears
23 July, 2002 by Tanya HollisA greater focus was needed on advancing Australia's pre-clinical development capabilities, a biotechnology conference was told today.
Cardia to research diabetes links
23 July, 2002 by Melissa TrudingerCardia Technologies has signed an option agreement worth $10,000 on diabetes type 1 food toxin research at the International Diabetes Institute (IDI).
New ResMed devices win US approval
22 July, 2002 by Melissa TrudingerMeditech company ResMed's latest sleep apnoea devices, the S7 Elite CPAP and AutoSet Spirit autotitrating devices, have been approved by the FDA for sale in the USA.
New CSIRO spin-off to develop drugs from bugs
22 July, 2002 by Tanya HollisThink twice before you next swat an insect - it could end up saving your life. A collaboration of leading research organisations has formed a private company to screen an insect library for potentially therapeutic molecules.
pSivida technology in new drug delivery trial
22 July, 2002 by Iain ScottA new deal will see an unnamed UK biopharma using nanotechnology developed by Perth biotech pSivida in vaccine delivery trials.
Norwood joins with US company to market anaesthetic
22 July, 2002 by Tanya HollisLaser drug delivery group Norwood Abbey has finalised an agreement with United States drug company Ferndale Laboratories over the joint marketing of an anaesthetic product.
